Healthcare stocks with low PE ratio to keep a watch onHealthcare stocks with low PE ratio to keep a watch on

Healthcare stocks with low price-to-earnings (PE) ratios offer attractive investment opportunities, indicating potential undervaluation compared to industry peers. Investors often seek such stocks for strong fundamentals, steady earnings, and long-term growth prospects in the ever-expanding healthcare sector.

A low PE ratio suggests a stock may be trading below its intrinsic value, making it an appealing choice for value investors. With rising demand for healthcare services, pharmaceuticals, and medical technology, these stocks can provide stable returns and resilient market performance.

Also Read: EV stock jumps 4% after it reports ₹382.44 Cr profit against loss of ₹621.6 Cr in previous qtr

Narayana Hrudaya

On February 7, 2025, Narayana Hrudayalaya Ltd opened at ₹1,399.95, up from its previous close of ₹1,372.70. The stock hit a high of ₹1,408.90 and a low of ₹1,365.00. By 4:00 PM, it traded at ₹1,405.90, up 2.42%, with a market cap of ₹28,731.09 crore.

Narayana Hrudayalaya Ltd has a low PE ratio of 35.6, indicating potential undervaluation. With strong earnings and a vast healthcare network, it remains an attractive investment in India’s growing multispecialty and super-specialty hospital sector.

Narayana Hrudayalaya Ltd (NSE: NH) is a leading healthcare provider offering economical medical services through 40 facilities, including multispecialty hospitals, heart centers, and clinics. It specializes in cardiac sciences, oncology, renal care, neurosciences, orthopedics, and gastrointestinal treatments.

Krsnaa Diagnostics

On February 7, 2025, Krsnaa Diagnostics Ltd opened at ₹864.25, down from its previous close of ₹880.05. The stock hit a high of ₹884.95 and a low of ₹864.25. By 4:01 PM, it traded at ₹877.70, down 0.27%, with a market cap of ₹2,834.07 crore.

Krsnaa Diagnostics Ltd has a low PE ratio of 38.1, suggesting it may be undervalued compared to industry peers. This highlights strong earnings potential, making it an appealing investment in the expanding diagnostics and healthcare sector.

Krsnaa Diagnostics Ltd (NSE: KRSNAA) is a leading diagnostics service provider offering imaging, pathology, and teleradiology services. With a strong presence in PPP diagnostics, it serves hospitals, medical colleges, and health centers across India’s non-metro and lower-tier cities.

Also Read: Damani stock falls 9% despite reporting 54% YoY increase in net profits

Dr Agarwal’s Eye

On February 7, 2025, Dr. Agarwal’s Eye Hospital Ltd. opened at ₹4,361.10, slightly up from its previous close of ₹4,361.05. The stock reached a high of ₹4,444.30 and a low of ₹4,006.65. By 4:01 PM, it traded at ₹4,038.20, down 7.40%, with a market cap of ₹1,897.95 crore.

Dr Agarwal’s Eye Hospital Ltd has a low PE ratio of 42.9, indicating potential undervaluation compared to industry peers. This reflects strong earnings potential, making it an attractive investment option in the growing eye-care and healthcare sector.

Dr Agarwal’s Eye Hospital Ltd (BSE: 526783) is a leading eye-care provider with a strong presence in Tamil Nadu. It offers comprehensive treatments, including cataract, glaucoma, laser correction, retina care, and refractive surgeries through its specialized eye hospitals.

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.